Cilostazol and Nimodipine Combined Therapy After Aneurysmal Subarachnoid Hemorrhage (aSAH)

NCT04148105 · clinicaltrials.gov ↗

PHASE4

Phase

TERMINATED

Status

19

Enrollment

OTHER

Sponsor class

Stopped Insufficient recruitment

Conditions

Aneurysmal Subarachnoid Hemorrhage

Interventions

DRUG: Cilostazol 100 MG
OTHER: Placebo

Sponsor

Henry Ford Health System